Press Releases

The World Health Organization (WHO) has just prequalified a two-pills-in-one pediatric medicine that is critical for the continuation phase of

HAMBURG, July 10 2017 – TB Alliance joins a coalition of 35 worldwide health advocates as well as numerous individuals from research institutes,

On May 23, 2017, the World Health Assembly elected Dr. Tedros Adhanom Ghebreyesus as the next Director-General of the World Health Organization.

BRUSSELS, 11 MAY 2017 — Leaders from the governments of France and the Netherlands today urged funding for new treatment

NEW YORK and GENEVA, 24 March 2017 — On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP)

TB Alliance and the broader TB community urge that the World Health Organization (WHO) add Mycobacterium tuberculosis to the critical

NEW YORK (21 December, 2016)—TB Alliance announced, based on positive results from the Phase 2b NC-005 trial, that it will

The government of Germany has announced its support for the development of new treatments to combat tuberculosis (TB). Germany’s Federal

October 27, 2016 (LIVERPOOL, ENGLAND) – TB Alliance, a non-profit organization dedicated to developing better and faster cures for tuberculosis (TB),

“The newly released global tuberculosis (TB) report from World Health Organization (WHO) is reporting the grim reality that more people are